it's the end of the line
for lateral flow testing

Meet the next generation, lab-comparable,

low price COVID-19 test


Upgrade to a more
accurate antigen test

  • A positive percent agreement of 95.6% in patients with a Ct value <30 and a negative percent agreement of 99.31% versus RT-PCR
  • Higher analytical sensitivity than many Lateral Flow Tests



Upgrade to better accuracy
at a low price point

  • Lateral flow comparable pricing
  • This low cost point is possible due to Amira’s unique and efficient test strip design

Upgrade to fast and
user friendly workflow

  • 15 minute test turnaround time with intuitive workflow.
  • The instrument reports the results, which reduces errors and the need to subjectively read test lines.



Upgrade to a next generation test backed by the industry’s leading microfluidic experts

  • Based on over 8 years of research and 30 years of diagnostics leadership, Amira condenses the principles of large, laboratory analyzers into a rapid, accurate instrument.
  • Industry leading manufacturing capacity means supply security for you and your patients, employees, and families.

The Amira SARS-CoV-2 Ag test comprises of:

  • Amira Analyzer
  • 200 SARS-CoV-2 Ag Test Strips
  • 200 nasal swabs
  • 200 sample tubes & applicators
  • Batteries
  • Sample stand

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. Not available in the USA.


Supporting healthier lives, for individuals, communities and wider society

Enabling responsive, personal relationships between patients and care teams.

Controlling and reducing costs to help ease pressure on healthcare budgets.

Be Informed